Pharmacodynamic Evaluation and Physical/Chemical Analysis of Two Formulations of Propofol used in Target-Controlled Infusion

Background and objectives: There are several formulations of propofol available to the anesthesiologist for clinical use. The aim of this study was to analyze the physicochemical properties, pharmacodynamic effect, and pharmaceutical and clinical equivalence of the reference drug propofol as well as...

Full description

Bibliographic Details
Main Authors: Ricardo Francisco Simoni, Luiz Eduardo de Paula Gomes Miziara, Luis Otávio Esteves, João Gilberto Ribeiro D’Castro, Carlos Alberto Morales, Jr., Carlos Eduardo Esqueapatti Sandrin, Thaís Costa Contente, Diogo Oliveira-Silva
Format: Article
Language:English
Published: Elsevier 2013-01-01
Series:Brazilian Journal of Anesthesiology
Online Access:http://www.sciencedirect.com/science/article/pii/S0104001413000213
id doaj-6c89a9f6bf2d4db88e40782a02c0a4cb
record_format Article
spelling doaj-6c89a9f6bf2d4db88e40782a02c0a4cb2020-11-24T22:08:59ZengElsevierBrazilian Journal of Anesthesiology0104-00142013-01-016315965Pharmacodynamic Evaluation and Physical/Chemical Analysis of Two Formulations of Propofol used in Target-Controlled InfusionRicardo Francisco Simoni0Luiz Eduardo de Paula Gomes Miziara1Luis Otávio Esteves2João Gilberto Ribeiro D’Castro3Carlos Alberto Morales, Jr.4Carlos Eduardo Esqueapatti Sandrin5Thaís Costa Contente6Diogo Oliveira-Silva7TSA; MD; Co-responsible for Centro de Ensino e Treinamento (CET) from Sociedade Brasileira de Anestesiologia (SBA), Instituto Penido Burnier and Centro Médico de Campinas; Corresponding author. Instituto Penido Burnier e Centro Médico de Campinas Avenida Andrade Neves, 611 13013-161, Campinas, SP, Brazil.Anesthesiologist, Hospital Santa Sofia and Centro Médico de CampinasTSA; Co-responsible for CET-SBA, Instituto Penido Burnier and Centro Médico de CampinasME3; CET-SBA Instituto Penido Burnier and Centro Médico de CampinasME3; CET-SBA Instituto Penido Burnier and Centro Médico de CampinasME3; CET-SBA Instituto Penido Burnier and Centro Médico de CampinasPhD; Researcher at Faculdade de Ciências Farmacêuticas, Universidade de São PauloPhD; Associate Professor at Universidade Federal de São Paulo (Unifesp), Campus DiademaBackground and objectives: There are several formulations of propofol available to the anesthesiologist for clinical use. The aim of this study was to analyze the physicochemical properties, pharmacodynamic effect, and pharmaceutical and clinical equivalence of the reference drug propofol as well as a similar formulation. Method: Sixteen volunteers were enrolled in this randomized, double-blind, and paired study of Diprivan® and Propovan® formulations. Formulations were given as target-controlled infusion with target concentration of 3.0 μg.mL-1 for 15 minutes. Variables studied were the area under the curve (AUC) of the bispectral index (BIS) graph regarding time, minimum BIS reached and time to reach it, and recovery time. The two formulations were sent to analysis of particle size of lipid emulsion, surface potential, and active principle quantification. Results: There was no difference between the formulations when comparing AUC, minimum BIS reached and time to reach it. The similar formulation recovery time was lower compared to the reference formulation (eight and 10 min, respectively, p = 0.014). Mean particle size of lipid emulsion, surface potential, and active ingredient quantification were similar for both formulations. Conclusion: There was no clinically significant difference between the use of propofol, reference Diprivan®, and the similar Propovan® during infusion. However, the recovery time was longer with the reference drug. Although analysis of both formulations studied show similar results regarding its physicochemical characterization, further studies should be conducted to justify this difference. Keywords: Anesthesia, Intravenous, Consciousness Monitors, Pharmacology, Clinical, Propofolhttp://www.sciencedirect.com/science/article/pii/S0104001413000213
collection DOAJ
language English
format Article
sources DOAJ
author Ricardo Francisco Simoni
Luiz Eduardo de Paula Gomes Miziara
Luis Otávio Esteves
João Gilberto Ribeiro D’Castro
Carlos Alberto Morales, Jr.
Carlos Eduardo Esqueapatti Sandrin
Thaís Costa Contente
Diogo Oliveira-Silva
spellingShingle Ricardo Francisco Simoni
Luiz Eduardo de Paula Gomes Miziara
Luis Otávio Esteves
João Gilberto Ribeiro D’Castro
Carlos Alberto Morales, Jr.
Carlos Eduardo Esqueapatti Sandrin
Thaís Costa Contente
Diogo Oliveira-Silva
Pharmacodynamic Evaluation and Physical/Chemical Analysis of Two Formulations of Propofol used in Target-Controlled Infusion
Brazilian Journal of Anesthesiology
author_facet Ricardo Francisco Simoni
Luiz Eduardo de Paula Gomes Miziara
Luis Otávio Esteves
João Gilberto Ribeiro D’Castro
Carlos Alberto Morales, Jr.
Carlos Eduardo Esqueapatti Sandrin
Thaís Costa Contente
Diogo Oliveira-Silva
author_sort Ricardo Francisco Simoni
title Pharmacodynamic Evaluation and Physical/Chemical Analysis of Two Formulations of Propofol used in Target-Controlled Infusion
title_short Pharmacodynamic Evaluation and Physical/Chemical Analysis of Two Formulations of Propofol used in Target-Controlled Infusion
title_full Pharmacodynamic Evaluation and Physical/Chemical Analysis of Two Formulations of Propofol used in Target-Controlled Infusion
title_fullStr Pharmacodynamic Evaluation and Physical/Chemical Analysis of Two Formulations of Propofol used in Target-Controlled Infusion
title_full_unstemmed Pharmacodynamic Evaluation and Physical/Chemical Analysis of Two Formulations of Propofol used in Target-Controlled Infusion
title_sort pharmacodynamic evaluation and physical/chemical analysis of two formulations of propofol used in target-controlled infusion
publisher Elsevier
series Brazilian Journal of Anesthesiology
issn 0104-0014
publishDate 2013-01-01
description Background and objectives: There are several formulations of propofol available to the anesthesiologist for clinical use. The aim of this study was to analyze the physicochemical properties, pharmacodynamic effect, and pharmaceutical and clinical equivalence of the reference drug propofol as well as a similar formulation. Method: Sixteen volunteers were enrolled in this randomized, double-blind, and paired study of Diprivan® and Propovan® formulations. Formulations were given as target-controlled infusion with target concentration of 3.0 μg.mL-1 for 15 minutes. Variables studied were the area under the curve (AUC) of the bispectral index (BIS) graph regarding time, minimum BIS reached and time to reach it, and recovery time. The two formulations were sent to analysis of particle size of lipid emulsion, surface potential, and active principle quantification. Results: There was no difference between the formulations when comparing AUC, minimum BIS reached and time to reach it. The similar formulation recovery time was lower compared to the reference formulation (eight and 10 min, respectively, p = 0.014). Mean particle size of lipid emulsion, surface potential, and active ingredient quantification were similar for both formulations. Conclusion: There was no clinically significant difference between the use of propofol, reference Diprivan®, and the similar Propovan® during infusion. However, the recovery time was longer with the reference drug. Although analysis of both formulations studied show similar results regarding its physicochemical characterization, further studies should be conducted to justify this difference. Keywords: Anesthesia, Intravenous, Consciousness Monitors, Pharmacology, Clinical, Propofol
url http://www.sciencedirect.com/science/article/pii/S0104001413000213
work_keys_str_mv AT ricardofranciscosimoni pharmacodynamicevaluationandphysicalchemicalanalysisoftwoformulationsofpropofolusedintargetcontrolledinfusion
AT luizeduardodepaulagomesmiziara pharmacodynamicevaluationandphysicalchemicalanalysisoftwoformulationsofpropofolusedintargetcontrolledinfusion
AT luisotavioesteves pharmacodynamicevaluationandphysicalchemicalanalysisoftwoformulationsofpropofolusedintargetcontrolledinfusion
AT joaogilbertoribeirodcastro pharmacodynamicevaluationandphysicalchemicalanalysisoftwoformulationsofpropofolusedintargetcontrolledinfusion
AT carlosalbertomoralesjr pharmacodynamicevaluationandphysicalchemicalanalysisoftwoformulationsofpropofolusedintargetcontrolledinfusion
AT carloseduardoesqueapattisandrin pharmacodynamicevaluationandphysicalchemicalanalysisoftwoformulationsofpropofolusedintargetcontrolledinfusion
AT thaiscostacontente pharmacodynamicevaluationandphysicalchemicalanalysisoftwoformulationsofpropofolusedintargetcontrolledinfusion
AT diogooliveirasilva pharmacodynamicevaluationandphysicalchemicalanalysisoftwoformulationsofpropofolusedintargetcontrolledinfusion
_version_ 1725813584861069312